Underweight LMT at 15-20% of benchmark with $552 stop and two-of-three re-entry framework
Underweight at 15-20% of benchmark with $552 stop and two-of-three re-entry framework. This is a timing call, not a quality call—the structural thesis remains intact with $173B backlog and beta 0.11 protection, but confirmed technical breakdown (200 SMA break at $550.69, accelerating MACD sequence) warrants grinding underperformance capture. The convergent analyst view is correct on direction; the trader overshoots on stop width (resolved at $552), the conservative undershoots on position size (resolved at 15-20% rather than 10%), and the neutral overfits on re-entry discipline (resolved at two-of-three rather than three).
| Position | Action |
|---|---|
| Standard Underweight sizing (60-70% reduction from current exposure) | Trim to 15-20% of benchmark weighting |
| Price triggers stop-loss | Exit position at $552 (1.9x ATR above entry, just above 200 SMA retest zone) |
LMT at $524 represents a high-conviction BUY with 26% upside to UBS's $674 price target, driven by accelerating backlog growth (43% over four years to $12.15B), confirmed margin recovery (Q2 2026 operating margin at 12.35%), and structural European rearmament demand converting into confirmed contracts—technical weakness is noise, not signal.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 541.59 | bearish |
| close_50_sma | 552.93 | bearish |
| close_200_sma | 550.69 | bearish |
| rsi | 36.48 | bearish |
| macd | -9.43 | bearish |
| macdh | -5.90 | bearish |
| atr | 14.19 | neutral |
| vwma | 550.15 | bearish |
Support: 524.37 · 510.22 · 490 · 496 | Resistance: 541.59 · 550.69 · 552.93 · 563.04 · 590 · 605
LMT has flipped from a recovery uptrend (May-Aug 2026) to a confirmed short-term downtrend, with all key moving averages converging in a ~$12 band near $551. The 200-day SMA at $550.69 has been breached on a closing basis for the first time in the dataset—a critical structural breakdown. Momentum is decisively negative: MACD crossed into negative territory on Aug 31 and has accelerated to -9.43, with the histogram's red bars expanding (now -5.90), confirming strengthening downside pressure rather than mere profit-taking. RSI at 36.48 shows bearish divergence from the Aug 18 high ($603.44) where RSI only reached 63.7 vs. 70.6 on Jul 28, but has not yet breached the 30 oversold threshold needed for a potential bounce signal. ATR of 14.19 (~2.7% of price) signals elevated volatility warranting wider stops of 1.5–2×ATR ($497–$503). VWMA at $550.15 has converged with the 200 SMA, confirming the decline is volume-supported (distribution, not capitulation—Sep 9 volume of 1.37M shares is modestly elevated but below true capitulation levels of 1.5M+). Support sits at $524.37 (Sep 9 intraday low), $510.22 (Bollinger Lower Band), and $490–$500 (June 22 trough and April cycle low at $497.25). Resistance at $541.59 (10 EMA), $550.69 (200 SMA), $552.93 (50 SMA), and $563.04 (Bollinger Middle Band). The final transaction proposal is HOLD: the first close below the 200 SMA often produces short-term bounces, but ATR-elevated volatility punishes premature positioning in either direction. A high-probability setup will emerge when RSI prints below 30 with a bullish hook, or price reclaims the 200 SMA with a positive MACD histogram.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MACD histogram contracting for 2 consecutive sessions + price reclaim $551 on volume (≥1.2M)
Then: Trigger 50% re-add of trimmed size
EV: +26% · concedes: Program concentration risk: F-35 represents ~25% of revenue and could face delays, cancellations, or restructuring under defense procurement reform; Bear's technical thesis: First close below 200 SMA ($550.69) signals bearish regime change; MACD at -9.43 and accelerating lower with expanding red histogram; price is below all major moving averages; Revenue growth lag: Revenue only grew 14% over four years despite backlog expansion; Market mispricing risk: Market may be pricing in durable peace despite only 22% ceasefire probability; RSI not yet oversold: RSI at 36.5 approaching but hasn't broken 30 threshold yet
LMT at $524 is a stock in transition pointing lower until the 200 SMA at $550.69 is reclaimed with conviction; the bear does not recommend shorting but explicitly advises against initiating new long positions at current valuations given unfavorable risk/reward.
· concedes: Backlog growth from $8.49B to $12.15B is real and deferred revenue improvement is confirmed; Q2 2026 margin at 12.35% is an improvement from 2024/2025 trough levels; UBS MFC growth thesis (+150% by 2030) has merit even if timing is uncertain; Defense sector underperformance of 20pp may be overdone at the margin; LMT is a fundamentally sound company with long-term defense spending tailwinds intact; Do not short the stock given ATR volatility and potential for oversold bounces
→ vs conservative: Holding through confirmed breakdown with 200 SMA breach, accelerating MACD, and 1.85x ATR gap is not conviction—it is refusing to adapt to momentum regime change
→ vs conservative: 7.5/10 bullish sentiment is a lagging indicator; the UBS upgrade, HIMARS contract, and EU Patriot approval already played out from $511 to $604
→ vs conservative: Polymarket ceasefire probability rising to 22% (up 5pp) is the wrong direction for the missile demand thesis
→ vs neutral: HOLD with full exposure at $524 while 200 SMA sits $26 above and MACD histogram expands red bars maximizes drawdown, not reduces it
→ vs conservative: Trim preserves the fundamental thesis while harvesting opportunity cost of holding through a confirmed downtrend; you can reload on bounce with tighter risk and better sizing
Market Capitalization
$121.04 billion
P/E Ratio (TTM)
19.33
Forward P/E
16.03
PEG Ratio
1.0
Price-to-Book
13.76
EPS (TTM)
$27.13
Forward EPS
$32.72
Dividend Yield
2.57%
Beta
0.104
52-Week High
$692.00
52-Week Low
$437.25
50-Day Moving Average
$555.50
200-Day Moving Average
$557.17
Revenue 2025
$75.05 billion
Revenue 2024
$71.04 billion
Revenue 2023
$67.57 billion
Net Income 2025
$5.02 billion
Net Income 2023
$6.92 billion
Diluted EPS 2025
$21.49
Diluted EPS Q2 2026
$7.94
Diluted EPS Q2 2025
$1.46
Operating Margin 2025
10.30%
Operating Margin Q2 2026
12.35%
Operating Margin Q2 2025
4.12%
Gross Margin (TTM)
11.80%
Operating Margin (TTM)
11.96%
Net Profit Margin (TTM)
8.16%
Return on Equity (ROE)
89.17%
Return on Assets (ROA)
8.64%
Stockholders' Equity Q2 2026
$8.77 billion
Stockholders' Equity YE2025
$6.72 billion
Total Debt Q2 2026
$20.54 billion
Net Debt Q2 2026
$16.75 billion
Debt/Equity
234.24%
Current Ratio
1.19
Cash and Equivalents Q2 2026
$3.79 billion
Receivables Q2 2026
$19.39 billion
Current Deferred Revenue Q2 2026
$12.15 billion
Goodwill and Intangibles Q2 2026
$13.09 billion
Net Tangible Book Value
-$4.32 billion
Working Capital Q2 2026
$4.59 billion
Operating Cash Flow 2025
$8.56 billion
Free Cash Flow 2025
$6.91 billion
Free Cash Flow (TTM)
$5.56 billion
FCF Yield
4.6%
CapEx 2025
$1.65 billion
CapEx/Revenue
2.2%
Dividends Paid 2025
$3.13 billion
Buybacks 2025
$3.00 billion
Total Capital Returned 2025
$6.13 billion
Diluted Shares 2021
264.6 million
Diluted Shares 2025
233.5 million
Interest Expense 2025
$1.12 billion
Tax Rate 2025
15.28%
Revenue Q2 2026
$20.06 billion
Revenue Q1 2026
$18.02 billion
YoY Revenue Growth Q2 2026
+10.5%
4-Year Revenue Growth
+13.8%
Retained Earnings Q2 2026
$15.76 billion
Non-Current Pension Liabilities
$3.93 billion
Strengths
Concerns
Lockheed Martin is a large-cap defense contractor with a market cap of $121.04B trading at a forward P/E of 16.03x with ~20.6% expected EPS growth. The company demonstrated strong margin recovery in Q2 2026 with operating margin of 12.35% and EPS of $7.94, up significantly from the depressed Q2 2025 levels. Revenue grew 10.5% YoY to $20.06B in Q2 2026, with backlog indicators surging 43% since 2022 to $12.15B. The company generates robust $5.56B in trailing free cash flow supporting ~$6.1B in annual capital returns, while deleveraging with net debt declining from $20.4B to $16.75B. However, long-term margin compression from 12.6% in 2021 to 10.2% in 2025, high 234% debt-to-equity ratio, and negative tangible book value of -$4.32B remain fundamental concerns. The ultra-low beta of 0.104 and 2.57% dividend yield make it suitable for defensive income-oriented portfolios.
Macro: Prediction market data (Polymarket, September 9, 2026): No Fed rate cuts in 2026 priced at 93% probability ($8.2M volume, +4.0pp week-over-week), with markets bracing for potential rate hikes. US recession probability by end-2026 stands at 8%, supporting a soft-landing base case. Russia-Ukraine ceasefire probability by December 31, 2026 is 22% (up +5.0pp WoW), implying continued conflict and European restocking demand. US official declaration of war on Iran by year-end is just 2%, indicating declining geopolitical tail-risk premium. US-China tariff agreement by year-end is priced at 90% probability, suggesting tariff overhang is expected to resolve favorably.